Literature DB >> 33925979

Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression.

Gonçalo Mesquita1,2,3, Natalia Prevarskaya1,2, Albrecht Schwab3, V'yacheslav Lehen'kyi1,2.   

Abstract

The transient receptor potential channels (TRPs) have been related to several different physiologies that range from a role in sensory physiology (including thermo- and osmosensation) to a role in some pathologies like cancer. The great diversity of functions performed by these channels is represented by nine sub-families that constitute the TRP channel superfamily. From the mid-2000s, several reports have shown the potential role of the TRP channels in cancers of multiple origin. The pancreatic cancer is one of the deadliest cancers worldwide. Its prevalence is predicted to rise further. Disappointingly, the treatments currently used are ineffective. There is an urgency to find new ways to counter this disease and one of the answers may lie in the ion channels belonging to the superfamily of TRP channels. In this review, we analyse the existing knowledge on the role of TRP channels in the development and progression of pancreatic ductal adenocarcinoma (PDAC). The functions of these channels in other cancers are also considered. This might be of interest for an extrapolation to the pancreatic cancer in an attempt to identify potential therapeutic interventions.

Entities:  

Keywords:  TRP channels; ion channels; pancreatic ductal adenocarcinoma

Year:  2021        PMID: 33925979     DOI: 10.3390/cells10051021

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  115 in total

1.  Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans.

Authors:  Narender R Gavva; James J S Treanor; Andras Garami; Liang Fang; Sekhar Surapaneni; Anna Akrami; Francisco Alvarez; Annette Bak; Mary Darling; Anu Gore; Graham R Jang; James P Kesslak; Liyun Ni; Mark H Norman; Gabrielle Palluconi; Mark J Rose; Margaret Salfi; Edward Tan; Andrej A Romanovsky; Christopher Banfield; Gudarz Davar
Journal:  Pain       Date:  2008-03-11       Impact factor: 6.961

2.  Increased vascular smooth muscle contractility in TRPC6-/- mice.

Authors:  Alexander Dietrich; Michael Mederos Y Schnitzler; Maik Gollasch; Volkmar Gross; Ursula Storch; Galyna Dubrovska; Michael Obst; Eda Yildirim; Birgit Salanova; Hermann Kalwa; Kirill Essin; Olaf Pinkenburg; Friedrich C Luft; Thomas Gudermann; Lutz Birnbaumer
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 3.  Molecular mechanisms of tumour invasion: regulation by calcium signals.

Authors:  Oksana Iamshanova; Alessandra Fiorio Pla; Natalia Prevarskaya
Journal:  J Physiol       Date:  2017-04-21       Impact factor: 5.182

4.  TRPV4 helps Piezo1 put the squeeze on pancreatic acinar cells.

Authors:  Fred Gorelick; Michael H Nathanson
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

5.  Prolonged high fat/alcohol exposure increases TRPV4 and its functional responses in pancreatic stellate cells.

Authors:  L P Zhang; F Ma; S M Abshire; K N Westlund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-27       Impact factor: 3.619

Review 6.  Transient Receptor Potential (TRP) Channels in Head-and-Neck Squamous Cell Carcinomas: Diagnostic, Prognostic, and Therapeutic Potentials.

Authors:  Fruzsina Kiss; Krisztina Pohóczky; Arpad Szállási; Zsuzsanna Helyes
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

7.  Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer.

Authors:  He Song; Ming Dong; Jianping Zhou; Weiwei Sheng; Xin Li; Wei Gao
Journal:  Oncol Rep       Date:  2018-01-15       Impact factor: 4.136

8.  Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer.

Authors:  Srinivasa P Pothula; Zhihong Xu; David Goldstein; Andrew V Biankin; Romano C Pirola; Jeremy S Wilson; Minoti V Apte
Journal:  Br J Cancer       Date:  2016-01-14       Impact factor: 7.640

9.  The Transient Receptor Potential Melastatin 7 Channel Regulates Pancreatic Cancer Cell Invasion through the Hsp90α/uPA/MMP2 pathway.

Authors:  Pierre Rybarczyk; Alison Vanlaeys; Bertrand Brassart; Isabelle Dhennin-Duthille; Denis Chatelain; Henri Sevestre; Halima Ouadid-Ahidouch; Mathieu Gautier
Journal:  Neoplasia       Date:  2017-03-08       Impact factor: 5.715

Review 10.  The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.

Authors:  Yaojie Fu; Shanshan Liu; Shan Zeng; Hong Shen
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

View more
  3 in total

Review 1.  Ion Channel Involvement in Tumor Drug Resistance.

Authors:  Concetta Altamura; Paola Gavazzo; Michael Pusch; Jean-François Desaphy
Journal:  J Pers Med       Date:  2022-02-03

2.  The Association between TRP Channels Expression and Clinicopathological Characteristics of Patients with Pancreatic Adenocarcinoma.

Authors:  Nicoleta-Raluca Chelaru; Andrei Chiosa; Andrei Sorop; Andreea Spiridon; Florentina Cojocaru; Dan Domocos; Dana Cucu; Irinel Popescu; Simona-Olimpia Dima
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

3.  Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents.

Authors:  Wenjie Shi; Chen Li; Thomas Wartmann; Christoph Kahlert; Renfei Du; Aristotelis Perrakis; Thomas Brunner; Roland S Croner; Ulf D Kahlert
Journal:  J Pers Med       Date:  2022-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.